D.C. Marketplace encourages labs to remove race from kidney function test to advance equity
The Health Insurance Marketplace for the District of Columbia is encouraging labs to remove race as a variable in the estimated glomerular filtration rate (eGFR) formula commonly used to measure kidney function, as recommended by the National Kidney Foundation and American Society of Nephrology to support health equity. The use of race in the equation for eGFR can exacerbate disparities in health outcomes. The D.C. marketplace, known as DC Health Link, covers 100,000 enrollees and 5,300 employers in all 50 states.
Related News Articles
Headline
Joy A. Rhoden, AHA senior vice president and executive director of health outcomes and care transformation, explores the economic impact of health disparities…
Blog
Hospital and health system leaders are navigating workforce shortages, reimbursement pressures, caring for a sicker patient population and rising operational…
Headline
The AHA Aug. 11 released a new resource guide designed to address a critical gap by helping leaders understand and quantify the economic burden of…
Headline
The AHA is now offering custom innovation summits — proven, high-impact workshops designed to convene health care leaders and co-…
Blog
Despite medical advancements, maternal mortality rates have doubled since 1987. Yet more than 80% of pregnancy-related deaths have been deemed preventable.We…
Headline
Joy A. Rhoden, AHA senior vice president and executive director of health outcomes and care transformation, shares the AHA’s top strategic…